Opinion|Videos|December 8, 2023
Novel Agents Contributing to Evolving MDS Therapy Strategies
A panel of experts discusses how novel agents are impacting the treatment landscape for patients diagnosed with MDS.
Advertisement
Episodes in this series
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug
2
ACO-SWITCH to Evaluate Tafamidis-to-Acoramidis Switch in ATTR-CM
3
Unvaccinated COVID-19 Infection Tied to Higher Myocarditis Risk
4
As GLP-1 Costs Climb, Medicare Part D Plans Face a Reckoning
5